Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment

被引:17
作者
Qin, LF [1 ]
Lee, TKW [1 ]
Ng, IOL [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China
关键词
gene expression profile; cDNA array; hepatoma; cisplatin;
D O I
10.1016/S0024-3205(01)01554-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gene expression profiling with cDNA array allows simultaneous analysis of the gene expression pattern of a large number of genes and may enhance the investigation of the molecular mechanisms involved in the treatment of hepatocellular carcinoma with cisplatin. We used cDNA array technology to assess the acne expression profiles related to cell cycle regulation and apoptosis in human hepatoma Hep3B cells in response to cisplatin treatment. In Hep3B cells, apoptosis induced by cisplatin was p53-independent, and was associated with up-regulation of cell cycle regulators, pro-apoptotic genes, growth receptors, and genes involved in signal transduction. These included p33ING1, c-Ab1, Bax, insulin-like growth factor binding protein 3, Siva, cyclin D1, RhoA, and Raf-1. Down-regulation of cell cycle regulator CDC2 was observed. Semi-quantitative reverse transcription-polymerase chain reaction and/or Western blot analysis performed on seven of these genes confirmed their upregulation of gene expression. Such global analysis of the cytotoxic response to chemotherapeutic drugs may yield insight into the mechanisms of drug action and allow rational design of more effective treatment strategies. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:1677 / 1690
页数:14
相关论文
共 33 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]  
Afshari CA, 1999, CANCER RES, V59, P4759
[3]   Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells [J].
Blagosklonny, MV ;
Chuman, Y ;
Bergan, RC ;
Fojo, T .
LEUKEMIA, 1999, 13 (07) :1028-1036
[4]  
Blagosklonny MV, 1996, CANCER RES, V56, P1851
[5]  
Blanc C, 2000, CANCER RES, V60, P4386
[6]   ABNORMAL STRUCTURE AND EXPRESSION OF P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA [J].
BRESSAC, B ;
GALVIN, KM ;
LIANG, TJ ;
ISSELBACHER, KJ ;
WANDS, JR ;
OZTURK, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1973-1977
[7]   INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[8]   Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells [J].
Chen, F ;
Studzinski, GP .
EXPERIMENTAL CELL RESEARCH, 1999, 249 (02) :422-428
[9]   Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate [J].
Cuvillier, O ;
Pirianov, G ;
Kleuser, B ;
Vanek, PG ;
Coso, OA ;
Gutkind, JS ;
Spiegel, S .
NATURE, 1996, 381 (6585) :800-803
[10]  
EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275